Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer.
about
A holistic approach to targeting disease with polymeric nanoparticlesIntravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts.Nanotechnology in bladder cancer: current state of development and clinical practiceCell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization.Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer.Advances in intravesical therapy for urinary tract disorders.Peptide-modified nanoparticles inhibit formation of Porphyromonas gingivalis biofilms with Streptococcus gordonii.Distribution of PLGA-modified nanoparticles in 3D cell culture models of hypo-vascularized tumor tissue.Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.Increased endocytosis of magnetic nanoparticles into cancerous urothelial cells versus normal urothelial cells.The suppression of metastatic lung cancer by pulmonary administration of polymer nanoparticles for co-delivery of doxorubicin and Survivin siRNA.Enhanced anticancer potency by thermo/pH-responsive PCL-based magnetic nanoparticles.Nanoparticle-mediated drug delivery to treat infections in the female reproductive tract: evaluation of experimental systems and the potential for mathematical modeling.BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms
P2860
Q26865163-BAE3205B-3171-412F-8EE7-7EC5D8C0250DQ35882024-D5783AD8-5BF0-4E97-AD80-F00C5988F367Q36036029-53EA9EDF-41C6-4DD5-A0D4-4052F6C58D8BQ36414890-B7EACA7A-5FE2-4C8C-8CB7-C4F31384CE61Q36825251-D5DDE720-703B-41A7-8C78-9659651457B3Q37114371-9541FA71-4029-43C5-9B0B-532F08DD37C8Q40101308-3E05A453-A762-4F18-81EF-9D3C283432FDQ42114884-FA503F1E-64DF-4E5F-8879-7EA8CDA34995Q42656489-9D5E3ED6-5C15-44D3-B886-0D6522B0FF32Q47777493-D15E945C-168C-4F07-9ED3-4E62C3E64A92Q48971998-30C1D28D-7DE1-44DD-87EA-9A48621E364CQ50047453-9B113C40-971E-4835-8169-56EEEFF2510AQ54212001-7E9EA704-1B13-4484-B236-75E3A0561D35Q58737804-3A5A6E39-2688-4BE5-8144-58FBCE05DAC1
P2860
Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Surface-modified nanoparticles ...... NA in treating bladder cancer.
@en
Surface-modified nanoparticles ...... NA in treating bladder cancer.
@nl
type
label
Surface-modified nanoparticles ...... NA in treating bladder cancer.
@en
Surface-modified nanoparticles ...... NA in treating bladder cancer.
@nl
prefLabel
Surface-modified nanoparticles ...... NA in treating bladder cancer.
@en
Surface-modified nanoparticles ...... NA in treating bladder cancer.
@nl
P2093
P2860
P1476
Surface-modified nanoparticles ...... NA in treating bladder cancer.
@en
P2093
Adam B Hittelman
Darryl T Martin
Hristos Z Kaimakliotis
Jill M Steinbach
Jingchun Liu
Marcia A Wheeler
Robert M Weiss
Shogo Shimizu
W Mark Saltzman
P2860
P356
10.1158/1535-7163.MCT-13-0502
P577
2013-11-12T00:00:00Z